Prevalence of sleep disorder in type 2 Diabetics and effect of implementing continuous care model on sleep quality and disease control .

Prevalence of sleep disorder in type 2 Diabetics and effect of implementing continuous care model on sleep quality and disease control in 2012.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202269140N1

Enrollment

Registered

2012-04-11

Start date

2012-04-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Diabetes mellitus

Interventions

Intervention 1: In control group: measuring blood glucose and urea and creatinine and at the end of intervention assessment for sleep quality. Intervention 2: In intervention group: measuring blood g

Lifestyle

In control group: measuring blood glucose and urea and creatinine and at the end of intervention assessment for sleep quality.

In intervention group: measuring blood glucose and urea and creatinine and then implementing continuous care model for 6 weeks.

Eligibility

Sex/Gender

All

Age

50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- patients with type 2 diabetes; 2- having sleep disorders; 3- having no acute complications and able to response to questionnaire; 4- having no psychological disease; 5- not taking sedatives; 6- having willingness to participate in the study; 7- having no known effective disease on sleep; 8- not having a neonate or any person which is needing frequent noctural wakes up; 9- not having any night shift; 10- not having a habbit of day sleeping; 11- not having frequent trips which effect on normal sleeping; 12- not pregnant; 13- ages between 50-70 years old; 14- have diploma up to BA degree. Exclusion criteria: 1- no willingness to continue the study, 2- researcher found the exchange of educated information between two intervention and control groups, 3- change in activity, dietary habits and medications.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sleep quality. Timepoint: Before and 3 mounths after intervention. Method of measurement: Pitzburg Questionary.	—

Secondary

Measure	Time frame
Blood glucose, Urea, Creatinine. Timepoint: Before and 3 mounths after intervention. Method of measurement: Pitzburg Questionary,Clinical tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayyeh Golchin Rahni

Gonabad University Of Medical Sciences

somayyehgolchin@gmail.com+98 53 3722 1359

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026